ASIA — Asia Green Biotechnology Balance Sheet
0.000.00%
Last trade - 00:00- CA$0.54m
- CA$0.79m
Annual balance sheet for Asia Green Biotechnology, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.484 | 1.02 | 0.381 | 0.067 | 0.012 |
| Net Total Receivables | 0.01 | 0.013 | 0.06 | 0.049 | 0.056 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.514 | 1.05 | 0.441 | 0.116 | 0.068 |
| Net Intangible Assets | |||||
| Total Assets | 0.554 | 1.05 | 0.441 | 0.116 | 0.068 |
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Current Liabilities | 0.13 | 0.089 | 0.028 | 0.043 | 0.268 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.13 | 0.089 | 0.028 | 0.193 | 0.343 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 0.424 | 0.966 | 0.413 | -0.077 | -0.275 |
| Total Liabilities & Shareholders' Equity | 0.554 | 1.05 | 0.441 | 0.116 | 0.068 |
| Total Common Shares Outstanding |